Endexx Announces Successful Completion of Two Year Financial Audits

Company Advances Forward in Pursuit of Fully Reporting Status

CAVE CREEK, Az., Nov. 13, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Endexx Corporation (OTC PINK: EDXC), announced today that it has completed an audit of its financial statements for fiscal years 2015 and 2016.  The Company intends to become a fully reporting company with the U.S. Securities & Exchange Commission (SEC) to pursue near term up-listing to a higher OTC Market tier.

“With all of our latest developments which include the appointment of our COO Dustin Sullivan and our investment in EcoHealth Neuropathy, we are pleased to report today we are making significant progress on meeting the commitments to our shareholders to pursuing fully reporting status,” commented Chief Executive Officer of Endexx, Todd Davis.  “Completing the audit is the first step necessary to meet institutional investor requirements.”

The audited statements for 2015 and 2016 have been posted to OTC Markets, along with the certification document provided by the Auditors “Turner, Stone & Company, L.L.P.” The audit for fiscal years 2017 and 2018 will be completed by Dec. 31, triggering another milestone for Endexx.

“After the fiscal year 2018 audit is completed, Endexx will be in a position to file for an up-listing with OTC Markets to OTCQB, and thereafter, file a registration statement with the SEC,” said Mr. Davis.  

About Endexx

Endexx, with its collaborative partners and consultants, develops and distributes two consumable product lines derived from industrial hemp, which is organic and naturally rich in phyto-cannabinoids. Phyto-Bites® is its CBD-infused soft chews for dogs. The dog treats are formulated to promote health and support the reduction of separation anxiety, pain and inflammation. The company also has two technology products and services that launched in 2014 – the m3hub and the AutoSpense™. Both products provide essential solutions to promote regulatory compliance and full accountability through “seed to sale” inventory management and an “end of sale” technology integration. Based on principles developed by the pharmacological industry, the m3hub platform is the first standardized software solution for tracking pharmaceutical-grade marijuana that maintains compliance with federal, state and local regulations. It is intended to provide a smooth transition to eventual federal mandates. The AutoSpense™ is a commercial-grade inventory control and dispensing device that provides up-to-the-minute accounting details and ensures both product and patient security. By automating the dispensing process, AutoSpense™ increases productivity and reduces costs for marijuana retailers, while enhancing their service quality by reducing transaction time for customers.

Websites include: www.cbdunlimited.com, www.endexx.com and www.phytobites.com.

Safe Harbor Notice

This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the company’s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The company undertakes no obligation to update any forward-looking statements.

Contact:

For further investor and media information, contact:
Endexx Corporation
Todd Davis
Chairman & CEO
endexx@endexx.com
480-595-6900